Preventing T2DM After GDM With Immediate Postpartum Screening

Launched by UNIVERSITY OF MASSACHUSETTS, WORCESTER · Jun 12, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on finding a better way to screen for diabetes in women who had gestational diabetes (GDM) during their pregnancy. GDM is a type of diabetes that can develop during pregnancy and may increase the risk of developing Type 2 Diabetes later on. The goal of the study is to test a new approach for screening women for diabetes right after they give birth, while they are still in the hospital. This could help catch diabetes early and allow for better management of their health.

To be part of this trial, participants need to be women who were diagnosed with GDM during their pregnancy and plan to deliver at UMASS Memorial. They should also be able to provide consent and complete a glucose test right after giving birth. However, women who already have diabetes before pregnancy or have certain medical conditions that prevent them from taking the glucose test will not be eligible. If you join this study, you can expect to undergo a simple glucose test shortly after delivery to check your blood sugar levels, which can help guide your health care moving forward.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • pregnancy complicated by GDM as diagnosed with traditional two step testing in the third trimester according to Carpenter-Coustan Criteria
• • receiving prenatal care at UMASS Memorial and plans to deliver at UMASS Memorial
• • able and willing to provide informed consent
• • ability to complete immediate in hospital postpartum glucose testing
• • have evidence of impaired glucose metabolism defined as fasting glucose value of ≥126 mg/dL or 2-hour glucose value of ≥200 mg/dL
• Exclusion Criteria:
• • known diagnosis of pre-existing pre-gestational diabetes in pregnancy
• • inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test) in pregnancy or immediately postpartum
• • systemic steroid use